Clinical correlations of potential activity markers in systemic sclerosis

Annals of the New York Academy of Sciences

Volumn 1051, Issue , 2005, Pages 404-412

  Bečvář, Radim ^a,e   Stork J ^b   Pesakova V ^a   Stanova A ^a   Hulejova H ^a   Rysova L ^a   Zatloukalova A ^c   Zatloukal, P ^d   Jachymova M ^b   Pourova L ^b  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Private Pneumological Practice   (Czech Republic)

^d UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^e Na Slupi 4 Praha 2   (Czech Republic)

Author keywords

Activity; Adhesion molecules; Collagen metabolism; Interleukins; Systemic sclerosis

Indexed keywords

BIG ENDOTHELIN 1; CARBON MONOXIDE; DEOXYPYRIDINOLINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; PYRIDINOLINE; SOLUBLE INTERCELLULAR ADHESION MOLECULE 1; SOLUBLE INTERLEUKIN 2 RECEPTOR; SOLUBLE VASCULAR CELL ADHESION MOLECULE 1; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ADULT; AGED; CALCULATION; CLINICAL ARTICLE; COLLAGEN METABOLISM; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE ACTIVITY; DISEASE MARKER; FEMALE; FINGER; FOLLOW UP; FUNCTIONAL ASSESSMENT; HAND PALM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTE COUNT; LUNG CAPACITY; MALE; NORMAL VALUE; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SYSTEMIC SCLEROSIS; URINARY EXCRETION;

EID: 25444471513     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1361.082     Document Type: Conference Paper

References (17)

1. MEDSGER, T.A. 1985. Comment on scleroderma criteria cooperative study. In Systemic sclerosis (Scleroderma). C.M. Black & A.R. Myers, Eds.: 235-249. Gower Med. New York.
2. Xu, W., E.C. LEROY & E.A. SMITH. 1991. Fibronectin release by systemic sclerosis and normal dermal fibroblasts in response to TGF beta. J. Rheumatol. 18: 241-246.
3. ROBERTS, A.B., M.B. SPORN, R.K. ASSOIAN, et al. 1986. Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 83: 4167-4171.
4. KAHALEH, M.B. & E.G. LEROY. 1989. Interleukin-2 in scleroderma: correlation of serum levels with extent of skin involvement and disease duration. Ann. Intern. Med. 110: 446-450.
5. BLACK, C.M., A. MCWHIRTER, N.K. HARRISON, et al. Serum type III procollagen peptide concentrations in systemic sclerosis and Raynaud's phenomenon: relationship to disease duration. Br. J. Rheumatol. 28: 98-103.
6. IŠTOK, R., L. CZIRJÁK, J. LUKáǒ, et al. 2001. Increased urinary pyridinoline cross-link compound of collagen in patients with systemic sclerosis and Raynaud's phenomenon. Rheumatology 40: 140-146.
7. LEROY, E.G., C.M. BLACK, R. FLEISCHMAJER, et al. 1988. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J. Rheumatol. 15: 202-205.
8. TANIMOTO, K., S. OHNO, M. IMADA, et al. 2004. Utility of urinary pyridinoline and deoxypyridinoline ratio for diagnosis of osteoarthritis at temporomandibular joint. J. Oral. Pathol. Med. 33: 218-223.
9. RODNAN, G.P., E. LIPINSKI & J. LUKSICK. 1979. Skin thickness and collagen content in progressive systemic sclerosis and localized scleroderma. Arthritis Rheum. 22: 130-140.
10. MARICQ, H.R. 1984. Nailfold capillaroscopy and biopsy in scleroderma and related disorders. Dermatologica 168: 73-77.
11. SILMAN, A.J., A. AKESSON, J. NEWMAN, et al. 1998. Assessment of functional ability in patients with scleroderma: a proposed new disability assessment instrument. J. Rheumatol. 25: 79-83.
12. VALENTINI, G., A. DELLA ROSSA, S. BOMBARDIERI, et al. 2001. European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity indexes. Ann. Rheum. Dis. 60: 592-598.
13. DEGIANNIS, D., J.R. SEIBOLD & M. CZARNECKI. 1990. Soluble and cellular markers of immune activation in patients with systemic sclerosis. Clin. Immunol. Immunopathol. 56: 259-266.
14. ZACHARIAE, H., P. BJERRING, L. HALKIER-SøRENSEN, et al. 1994. Skin scoring in systemic sclerosis: a modification - relations to subtypes and aminoterminal propeptide of type III procollagen (PIIINP). Acta Derm. Venereol. 74: 444-446.
15. STUART, R.A., A.J. LITTLEWOOD, P.J. MADDISON & N.D. HALL. 1995. Elevated serum interleukin-6 levels associated with active disease in systemic connective tissue disorders. Clin. Exp. Rheumatol. 13: 17-22.
16. HEICKENDORFF, L., H. ZACHARIAE, P. BJERRING, et al. 1995. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis. J. Am. Acad. Dermatol. 32: 584-588.
17. CLEMENTS, P.J. 1995. Measuring disease activity and severity in scleroderma. Curr. Opin. Rheumatol. 7: 517-521.